DAIC

FEBRUARY 6, 2024

Getty Images milla1cf Tue, 02/06/2024 - 20:36 February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial ( NCT05883631 ), a study formally launched in late October 2023. The Ablamap System includes a workstation with software and monitor, amplifier, and proprietary basket mapping catheter and cables. "I

Ablation 104

Ablation Atrial Fibrillation AFIB Pulmonary 104

Dr. S. Venkatesan MD

OCTOBER 15, 2024

A new Intelligent thrombo-suction catheter system , is being introduced for treatment of acute pulmonary embolism.This device regulates the force with which thrombus is sucked , with less injury and bleeding and better outcomes. Human studies & Evidence The experience from this device was presented in ESC 2024 London.

Technology 52

Technology Pulmonary Embolism Innovation 52

DAIC

MAY 2, 2024

Getty Images milla1cf Thu, 05/02/2024 - 10:12 May 2, 2024 — BioCardia, Inc. ,

Ischemia 95

Ischemia Angina Heart Failure Outcomes 95

Circulation: Cardiovascular Interventions

JANUARY 20, 2025

BACKGROUND:The aim of this study was to examine the impact of early versus delayed catheter-based therapies (CBTs) on clinical outcomes in patients with acute intermediate-risk pulmonary embolism (PE).METHODS:This Secondary outcomes included a composite of 30-day mortality, resuscitated cardiac arrest, and hemodynamic instability.

Embolism 40

Embolism Pulmonary Outcomes Cardiac Arrest 40

DAIC

MAY 22, 2024

milla1cf Wed, 05/22/2024 - 07:00 May 22, 2024 — Voiant (USA) and Thirona (The Netherlands) announced they have entered a global commercial partnership, combining Voiant's expertise in supporting clinical trials in pulmonary drug and treatment development with Thirona's expertise in advanced lung image analysis.

Pulmonary 52

Pulmonary Research Outcomes 52

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4140065-A4140065, November 12, 2024. At 1-year follow-up, the secondary endpoint demonstrated no intergroup differences in outcome (91.7% Echocardiographic improvement and mid-term clinical outcomes were comparable in both groups (all P > 0.05). versus 86.0%; P = 0.605).

Pulmonary 40

Pulmonary Outcomes Circulation 40

DAIC

JUNE 13, 2024

Xeltis synthetic restorative pulmonary heart valve evolves into a fully functioning, natural heart valve through colonization by the patient’s own tissue. Paulo Neves , Chief Medical Officer, Xeltis said: “Our focus is on improving the outcomes for patients on dialysis.

Heart Valves 111

Heart Valves Technology Pulmonary Outcomes 111

DAIC

APRIL 18, 2024

Graphic courtesy of Dan Musat milla1cf Thu, 04/18/2024 - 13:32 April 18, 2024 — New evidence-based research calls into question the conventional three-month blanking period immediately after atrial fibrillation (AF) ablation, when early occurrences of AF are thought not to predict long-term AF recurrence.

Atrial Fibrillation 111

Atrial Fibrillation Ablation Heart Rhythm Article 111

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4143405-A4143405, November 12, 2024. The purpose of this study was to delineate the clinical features, hemodynamics, and outcomes of PH in COA.Method:Retrospective cohort study of adults with repaired COA that underwent right heart catheterization (RHC).

Pulmonary 40

Pulmonary Hypertension Outcomes Atrial Fibrillation 40

The American Journal of Cardiology

OCTOBER 29, 2024

Publication date: Available online 28 October 2024 Source: The American Journal of Cardiology Author(s): Aryan Mehta, Mridul Bansal, Siddhant Passey, Saurabh Joshi, Carlos L Alviar, Jason N Katz, J Dawn Abbott, Saraschandra Vallabhajosyula

Embolism 40

Embolism Pulmonary Outcomes 40

The American Journal of Cardiology

JANUARY 1, 2025

Publication date: Available online 31 December 2024 Source: The American Journal of Cardiology Author(s): Aryan Mehta, Mridul Bansal, Abhishek Singh, Ritika Kompella, Anindita Chanda, Chirag Mehta, Christopher J Mullin, J Dawn Abbott, Saraschandra Vallabhajosyula

Embolism 40

Embolism Pulmonary Hospital Outcomes 40

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

Patients in Group 2 had greater pulmonary artery systolic pressure than those in Group 1 (p-value<0.001). This is the first study in Ethiopia and sub-Saharan Africa to report on percutaneous closure of secundum atrial septal defects (ASD) in children, adolescents, and adults. Overall, 88.9%

Hospital 52

Hospital Exercise Tachycardia Pulmonary 52

The American Journal of Cardiology

APRIL 24, 2024

Publication date: Available online 23 April 2024 Source: The American Journal of Cardiology Author(s): Anand Maligireddy, Ahmad Jabri, Mohammad Zghouzi, Chaitanya Rojulpote, Gabriella VanAken, Chaitra Janga, Ryhm Radjef, Herbert Aronow, Rana Awdish, Bryan Kelly, Gillian Grafton, Timir K Paul, Chien-Jung Lin, Deana Mikhalkova, Khaldoon Alaswad, Domingo (..)

Pulmonary 40

Pulmonary Hypertension Outcomes 40

DAIC

JUNE 27, 2024

By leveraging Anumana's ECG-AI algorithms, developed and validated in collaboration with Mayo Clinic, this initiative aims to enhance InfoBionic.Ai’s MoMe ARC Platform’s ability to detect and intervene in cardiac diseases earlier in the remote patient monitoring setting, with the potential to improve patient outcomes.

Technology 105

Technology Heart Rhythm Innovation Heart Failure 105

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4144822-A4144822, November 12, 2024. Short-term outcomes include in-hospital mortality and 28-day mortality. According to the AG value (17.0 mmol/L), patients were divided into high and low AG groups. or 7.2%, respectively;P&lt; 0.001).

Pulmonary 40

Pulmonary ICU Hypertension Hospital 40

Circulation

NOVEMBER 24, 2024

Circulation, Volume 150, Issue 22 , Page e467-e467, November 26, 2024.

Article 45

Article Pulmonary Hypertension Circulation 45

DAIC

DECEMBER 29, 2023

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. "The The company now anticipates U.S.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4135095-A4135095, November 12, 2024. This study examines the outcomes of hospitalized AF patients with thrombocytopenia.Methods:The National Inpatient Sample (NIS) from 2016-2020 was analyzed to identify adult patients with AF and thrombocytopenia (using the proper ICD-10 codes).

Atrial Fibrillation 40

Atrial Fibrillation Outcomes Inpatient Hospital 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 11, 2024

recurrence rate signals the need for enhanced outcomes in this challenging population. Abstract Objectives To investigate tailored approaches, techniques, and outcomes of catheter ablation in patients with persistent left superior vena cava (PLSVC) undergoing atrial fibrillation (AF) ablation. However, a 46.7%

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes Pulmonary 40

The American Journal of Cardiology

NOVEMBER 21, 2024

Publication date: Available online 21 November 2024 Source: The American Journal of Cardiology Author(s): Giulia Masiero, Federico Arturi, Elisa Boscolo Soramio, Luca Nai Fovino, Tommaso Fabris, Francesco Cardaioli, Andrea Panza, Giulia Lorenzoni, Massimo Napodano, Chiara Fraccaro, Giuseppe Tarantini

Bicuspid/Mitral 40

Bicuspid/Mitral Pulmonary Outcomes 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4135252-A4135252, November 12, 2024. We compared in-hospital outcomes based on the presence versus absence of Group 2 PH. The primary outcome was 30-day readmissions. 4.58, p=0.001), mechanical ventilation use (aOR 2.07, 95% CI 1.19–3.6, p=0.010), vasopressor use (aOR 5.4,

Myocardial Infarction 40

Myocardial Infarction Hospital Hypertension Pulmonary 40

DAIC

MARCH 20, 2024

milla1cf Wed, 03/20/2024 - 18:53 March 20, 2024 — PECA Labs , a medical device company reimagining the field of vascular grafts and valves with durable polymeric cardiovascular devices designed to fit, grow, and last, has received an additional CE Mark for its exGraft family of vascular grafts , expanding its on-label use.

Pediatrics 105

Pediatrics Anatomy Technology Innovation 105

Frontiers in Cardiovascular Medicine

MARCH 3, 2025

Data collection included demographic characteristics, clinical outcomes, hospitalization details, and surgical treatment. Pulmonary vein abnormalities were observed in 4 ouf of 7 (57.1%) patients and atrial septal defects in 2 out of 7 patients (28.5%).

Congenital 52

Congenital Congenital Heart Disease Risk Factors Pulmonary 52

DAIC

FEBRUARY 2, 2024

milla1cf Fri, 02/02/2024 - 17:02 February 2, 2024 — Biosense Webster, Inc. , The results support the use of workflows to reduce radiation exposure during catheter ablation for the treatment of paroxysmal atrial fibrillation (AFib) while maintaining safety, efficacy, and long-term patient outcomes comparable to traditional procedures.1

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

DAIC

JANUARY 3, 2024

milla1cf Wed, 01/03/2024 - 11:59 January 3, 2024 — Cardionomic, Inc. , Both studies were designed to evaluate the safety and performance of the Cardiac Pulmonary Nerve Stimulation (CPNS) System in patients suffering from Acute Decompensated Heart Failure (ADHF), defined as new or worsening symptoms of heart failure.

Heart Failure 59

Heart Failure Pulmonary Inpatient Hospital 59

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATMP100-ATMP100, February 1, 2024. Analyzing acute ischemic stroke (AIS) trends and outcomes in MHO vs. metabolically healthy normal weight (MH-NW).Methods:Data Analyzing acute ischemic stroke (AIS) trends and outcomes in MHO vs. metabolically healthy normal weight (MH-NW).Methods:Data

Obesity 40

Obesity Stroke Strokes Outcomes 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A134-A134, February 1, 2024. Our primary study outcome was any stroke or major thrombotic event identified within 60 days of OHSS diagnosis in HCUP or during the index admission for OHSS in NIS. There were 1,955 hospitalizations for OHSS in NIS.

Thrombosis 40

Thrombosis Inpatient Embolism Myocardial Infarction 40

Journal of the American Heart Association

FEBRUARY 26, 2025

Stenotic lesions included 16 branch pulmonary arteries, 9 aortic isthmus, 2 right ventricular outflow tracts, and 1 Glenn anastomosis. ConclusionsOptimusL stents can safely treat arterial and venous stenosis in infants and small children via a lowprofile approach with good outcomes. male) with median age and weight of 3.4

Stent 45

Stent Stents Stenosis Congenital 45

Journal of Cardiovascular Pharmacology

SEPTEMBER 5, 2024

Abstract: Extracorporeal membrane oxygenation (ECMO) is a mechanical support treatment modality utilized in patients with refractory cardiac and/or pulmonary failure. This review of the evidence for bivalirudin utilization in ECMO suggests favorable outcomes in circuit-related thrombosis, bleeding, and dosing reliability.

Laboratory 40

Laboratory Thrombosis Pharmacology Pulmonary 40

DAIC

DECEMBER 26, 2023

Importantly, the speed and ease with which we were able to isolate the pulmonary veins with the nsPFA 360 catheter was impressive and all patients tolerated the procedure well. We look forward to continuing our catheter clinical program and to starting our cardiac surgery clinical program with our surgical nsPFA clamp in 2024.”

Ablation 59

Ablation Atrial Fibrillation Technology Cardiothoracic 59

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4144999-A4144999, November 12, 2024. Current recommendations for pulmonary valve replacement (PVR) in TOF patients use indexed RV endiastolic volume (RVEDVi) to determine timing of PVR. In the presence of obesity, RVEDVi may underestimate the severity of RV volume load.

Obesity 40

Obesity BMI Pulmonary Circulation 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A52-A52, February 1, 2024. We compared demographics, hospital traits, comorbidities, and outcomes. In-hospital mortality, our primary outcome, was analyzed through multivariate logistic regression using STATA 18.Results:Incorporating million (1990) to 3.29

Inpatient 40

Inpatient Stroke Strokes Coronary Artery Disease 40

Society of Thoracic Surgeons - Surgeon

MARCH 29, 2024

Ascension Saint Thomas Hospital Improves Performance through Better Medical Record Management KCummings Fri, 03/29/2024 - 08:54 Overview In the fast-paced environment of healthcare, hospitals face significant challenges related to medical records.

Hospital 49

Hospital Document Echocardiogram Nursing 49

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP151-AWP151, February 1, 2024. vs. 22.6%), HTN (17% vs. 14.7%), chronic pulmonary disease (13.2% Additionally, in-hospital outcomes like AIS (0.5% Introduction:Cannabis use and low socioeconomic status are recognized as distinct risk factors for stroke and cardiovascular pathologies.

Hospital 40

Hospital Stroke Strokes Medicaid 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4139791-A4139791, November 12, 2024. vs. Ctrl), indicative of pulmonary congestion. EMPA had positive outcome on cardiac remodeling in terms of left ventricle hypertrophy and enlargement (p&lt;0.05 Mean blood pressure was consistently increased in HFD/L-NAME mice (p&lt;0.05

Preserved Ejection Fraction 40

Preserved Ejection Fraction Hypertension Blood Pressure Obesity 40

Dr. Smith's ECG Blog

JANUARY 27, 2024

West J Emerg Med 2024). Fortunately they spontaneously reperfused, or else they could have had a worse outcome, but deferring all ‘normal’ ECGs will perpetuate delayed diagnosis and reperfusion for STEMI(-)OMI. See these posts: Chest Pain, ST Elevation, and an Elevated Troponin: Should we Activate the Cath Lab? Deutch et al.

Chest Pain 117

Chest Pain STEMI Aneurysm Stent 117

Dr. Smith's ECG Blog

FEBRUARY 6, 2024

Atrial fibrillation is also a predictor of worse outcomes in this case (Alborzi). Retrieved July 2, 2022, from [link] == MY Comment , by K EN G RAUER, MD ( 2/4 /2024 ): == Today's case by Dr. Meyers provides insight with regard to sequential evolution of serial ECGs during the course of cardiac contusion. & Burgersdijk, C.

Tachycardia 115

Tachycardia Dysrhythmia Atrial Fibrillation Bradycardia 115